CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 73 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,640,975 | -12.5% | 1,308,386 | +0.3% | 0.00% | 0.0% |
| Q3 2022 | $8,737,000 | +70.0% | 1,303,995 | +6.8% | 0.00% | 0.0% |
| Q2 2022 | $5,138,000 | +51.4% | 1,220,541 | +21.2% | 0.00% | – |
| Q1 2022 | $3,393,000 | +6.9% | 1,006,959 | -0.0% | 0.00% | – |
| Q4 2021 | $3,173,000 | -2.9% | 1,007,258 | +0.8% | 0.00% | – |
| Q3 2021 | $3,267,000 | -23.1% | 999,254 | -0.7% | 0.00% | – |
| Q2 2021 | $4,246,000 | -17.5% | 1,006,158 | -2.4% | 0.00% | -100.0% |
| Q1 2021 | $5,146,000 | -78.3% | 1,031,092 | -45.1% | 0.00% | -66.7% |
| Q4 2020 | $23,729,000 | +29.3% | 1,877,328 | +0.4% | 0.00% | +50.0% |
| Q3 2020 | $18,358,000 | -1.2% | 1,869,374 | +0.1% | 0.00% | -33.3% |
| Q2 2020 | $18,583,000 | +12.7% | 1,867,643 | +0.1% | 0.00% | 0.0% |
| Q1 2020 | $16,495,000 | -0.1% | 1,865,926 | +4.2% | 0.00% | +50.0% |
| Q4 2019 | $16,514,000 | +92.7% | 1,790,166 | +22.8% | 0.00% | +100.0% |
| Q3 2019 | $8,571,000 | -6.3% | 1,457,581 | +91.1% | 0.00% | 0.0% |
| Q2 2019 | $9,151,000 | +583.9% | 762,606 | +587.5% | 0.00% | – |
| Q1 2019 | $1,338,000 | +161.3% | 110,922 | +171.7% | 0.00% | – |
| Q4 2018 | $512,000 | +3.4% | 40,819 | +22.5% | 0.00% | – |
| Q3 2018 | $495,000 | -11.3% | 33,328 | +0.3% | 0.00% | – |
| Q2 2018 | $558,000 | -43.8% | 33,213 | -23.3% | 0.00% | – |
| Q1 2018 | $993,000 | -42.2% | 43,330 | -34.8% | 0.00% | – |
| Q4 2017 | $1,719,000 | +142.5% | 66,464 | +38.3% | 0.00% | – |
| Q3 2017 | $709,000 | +2.5% | 48,068 | -3.2% | 0.00% | – |
| Q2 2017 | $692,000 | -34.5% | 49,639 | -19.9% | 0.00% | – |
| Q1 2017 | $1,057,000 | +65.2% | 61,955 | -0.4% | 0.00% | – |
| Q4 2016 | $640,000 | +7.4% | 62,181 | +5.5% | 0.00% | – |
| Q3 2016 | $596,000 | -9.3% | 58,921 | +0.7% | 0.00% | – |
| Q2 2016 | $657,000 | -13.0% | 58,498 | +5.9% | 0.00% | – |
| Q1 2016 | $755,000 | -63.5% | 55,255 | -49.4% | 0.00% | – |
| Q4 2015 | $2,071,000 | +10.3% | 109,170 | +9.1% | 0.00% | – |
| Q3 2015 | $1,878,000 | +26.1% | 100,054 | +0.0% | 0.00% | – |
| Q2 2015 | $1,489,000 | -1.7% | 100,006 | +0.0% | 0.00% | -100.0% |
| Q1 2015 | $1,515,000 | +1546.7% | 100,000 | +1340.9% | 0.00% | – |
| Q4 2014 | $92,000 | -67.8% | 6,940 | -75.5% | 0.00% | – |
| Q2 2014 | $286,000 | – | 28,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |